The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Merilym 3, suspension for injection for dogs

Boehringer Ingelheim Vetmedica GmbHVPA10454/069/001

Main Information

Trade NameMerilym 3, suspension for injection for dogs
Active SubstancesBorrelia garinii
Borrelia afzelii
Borrelia burgdorferi sensu stricto
Dosage FormSuspension for injection
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/069/001

Group Information

ATC CodeQI07AB04 borrelia
Therapeutic ClassImmunological - Inactivated Vaccine


License statusAuthorised
Licence Issued10/05/2013
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back